|
1
|
van der Wal JE, Becking AG, Snow GB and
van der Waal I: Distant metastases of adenoid cystic carcinoma of
the salivary glands and the value of diagnostic examinations during
follow-up. Head Neck. 24:779–783. 2002.
|
|
2
|
Terhaard CH, Lubsen H, Van der Tweel I, et
al: Salivary gland carcinoma: independent prognostic factors for
locoregional control, distant metastases and overall survival:
results of the Dutch head and neck oncology cooperative group. Head
Neck. 26:681–693. 2004. View Article : Google Scholar
|
|
3
|
Honma K, Miyata T and Ochiya T: Type I
collagen gene suppresses tumor growth and invasion of malignant
human glioma cells. Cancer Cell Int. 7:122007. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
López-Otín C and Matrisian LM: Emerging
roles of proteases in tumour suppression. Nat Rev Cancer.
7:800–808. 2007.PubMed/NCBI
|
|
5
|
Visse R and Nagase H: Matrix
metalloproteinases and tissue inhibitors of metalloproteinases:
structure, function, and biochemistry. Circ Res. 92:827–839. 2003.
View Article : Google Scholar
|
|
6
|
Takahashi C, Sheng Z, Horan TP, et al:
Regulation of matrix metalloproteinase-9 and inhibition of tumor
invasion by the membrane-anchored glycoprotein RECK. Proc Natl Acad
Sci USA. 95:13221–13226. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Hsu MC, Chang HC and Hung WC: HER-2/neu
represses the metastasis suppressor RECK via ERK and Sp
transcription factors to promote cell invasion. J Biol Chem.
281:4718–4725. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Welm B, Mott J and Werb Z: Developmental
biology: vasculogenesis is a wreck without RECK. Curr Biol.
12:R209–R211. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Sasahara RM, Brochado SM, Takahashi C, et
al: Transcriptional control of the RECK metastasis/angiogenesis
suppressor gene. Cancer Detect Prev. 26:435–443. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Takagi S, Simizu S and Osada H: RECK
negatively regulates matrix metalloproteinase-9 transcription.
Cancer Res. 69:1502–1508. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Takenaka K, Ishikawa S, Yanagihara K, et
al: Prognostic significance of reversion-inducing cysteine-rich
protein with Kazal motifs expression in resected pathologic stage
IIIA N2 non-small-cell lung cancer. Ann Surg Oncol. 12:817–824.
2005. View Article : Google Scholar
|
|
12
|
Span PN, Sweep CG, Manders P, Beex LV,
Leppert D and Lindberg RL: Matrix metalloproteinase inhibitor
reversion-inducing cysteine-rich protein with Kazal motifs: a
prognostic marker for good clinical outcome in human breast
carcinoma. Cancer. 97:2710–2715. 2003. View Article : Google Scholar
|
|
13
|
Kang HG, Kim HS, Kim KJ, Oh JH, Lee MR,
Seol SM and Han I: RECK expression in osteosarcoma: correlation
with matrix metalloproteinases activation and tumor invasiveness. J
Orthop Res. 25:696–702. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Ko YH, Roh SY, Won HS, et al: Prognostic
significance of nuclear survivin expression in resected adenoid
cystic carcinoma of the head and neck. Head Neck Oncol. 2:302010.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Seifert G and Sobin LH: The World Health
Organization’s Histological Classification of Salivary Gland
Tumors. A commentary on the second edition. Cancer. 70:379–385.
1992.
|
|
16
|
Lee JH and Welch DR: Suppression of
metastasis in human breast carcinoma MDA-MB-435 cells after
transfection with the metastasis suppressor gene, KiSS-1. Cancer
Res. 57:2384–2387. 1997.
|
|
17
|
Welch DR, Steeg PS and Rinker-Schaeffer
CW: Molecular biology of breast cancer metastasis. Genetic
regulation of human breast carcinoma metastasis. Breast Cancer Res.
2:408–416. 2000. View
Article : Google Scholar : PubMed/NCBI
|
|
18
|
Yang J, Mani SA, Donaher JL, et al: Twist,
a master regulator of morphogenesis, plays an essential role in
tumor metastasis. Cell. 117:927–939. 2004. View Article : Google Scholar
|
|
19
|
Shirasuna K, Saka M, Hayashido Y, Yoshioka
H, Sugiura T and Matsuya T: Extracellular matrix production and
degradation by adenoid cystic carcinoma cells: participation of
plasminogen activator and its inhibitor in matrix degradation.
Cancer Res. 53:147–152. 1993.
|
|
20
|
Vihinen P and Kähäri VM: Matrix
metalloproteinases in cancer: prognostic markers and therapeutic
targets. Int J Cancer. 99:157–166. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Freitas VM, Vilas-Boas VF, Pimenta DC, et
al: SIKVAV, a laminin alpha1-derived peptide, interacts with
integrins and increases protease activity of a human salivary gland
adenoid cystic carcinoma cell line through the ERK 1/2 signaling
pathway. Am J Pathol. 171:124–138. 2007. View Article : Google Scholar
|
|
22
|
Takeuchi T, Hisanaga M, Nagao M, et al:
The membrane-anchored matrix metalloproteinase (MMP) regulator RECK
in combination with MMP-9 serves as an informative prognostic
indicator for colorectal cancer. Clin Cancer Res. 10:5572–5579.
2004. View Article : Google Scholar
|
|
23
|
Oh J, Takahashi R, Kondo S, et al: The
membrane-anchored MMP inhibitor RECK is a key regulator of
extracellular matrix integrity and angiogenesis. Cell. 107:789–800.
2001. View Article : Google Scholar
|
|
24
|
Sternlicht MD and Werb Z: How matrix
metalloproteinases regulate cell behavior. Annu Rev Cell Dev Biol.
17:463–516. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Sasahara RM, Takahashi C and Noda M:
Involvement of the Sp1 site in ras-mediated downregulation of the
RECK metastasis suppressor gene. Biochem Biophys Res Commun.
264:668–675. 1999. View Article : Google Scholar
|
|
26
|
Masui T, Doi R, Koshiba T, et al: RECK
expression in pancreatic cancer: its correlation with lower
invasiveness and better prognosis. Clin Cancer Res. 9:1779–1784.
2003.PubMed/NCBI
|
|
27
|
Furumoto K, Arii S, Mori A, et al: RECK
gene expression in hepatocellular carcinoma: correlation with
invasion-related clinicopathological factors and its clinical
significance. Reverse-inducing-cysteine-rich protein with Kazal
motifs. Hepatology. 33:189–195. 2001. View Article : Google Scholar
|
|
28
|
Yang X, Dai J, Li T, et al: Expression of
EMMPRIN in adenoid cystic carcinoma of salivary glands: correlation
with tumor progression and patients’ prognosis. Oral Oncol.
46:755–760. 2010.PubMed/NCBI
|
|
29
|
Yan KH, Lee LM, Yan SH, Huang HC, Li CC,
Lin HT and Chen PS: Tomatidine inhibits invasion of human lung
adenocarcinoma cell A549 by reducing matrix metalloproteinases
expression. Chem Biol Interact. 203:580–587. 2013. View Article : Google Scholar : PubMed/NCBI
|
